The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.
- 1 September 1978
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 6 (3) , 247-254
- https://doi.org/10.1111/j.1365-2125.1978.tb04593.x
Abstract
1 It has been suggested that the rate of metabolism of phenelzine is dependent on the acetylator phenotype of the recipient and, therefore, that acetylator phenotype may be an indicator of clinical importanc e.Keywords
This publication has 14 references indexed in Scilit:
- A Clinical Trial of Phenelzine in Anxiety Depressive and Phobic NeurosesThe British Journal of Psychiatry, 1977
- The myth of phenelzine acetylation.BMJ, 1976
- ACETYLATOR STATUS AND RESPONSE TO PHENELZINE IN DEPRESSED PATIENTSThe Lancet, 1973
- Phenelzine, Mood Response, and SleepArchives of General Psychiatry, 1973
- Simplified Method for Determining Acetylator PhenotypeBMJ, 1972
- A rapid accurate procedure for the determination of serotonin in whole human bloodBiochemical Medicine, 1970
- Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivoBiochemical Pharmacology, 1968
- A rapid quantitative method for the estimation of 5-hydroxyindoleacetic acid in human urineBiochemical Pharmacology, 1966
- Determination of 3-methoxy-4-hydroxymandelic acid in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1962
- Variance and Covariance Analyses for Unbalanced ClassificationsBiometrics, 1957